Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial
Abstract Background Adherence to treatment, i.e. the extent to which a patient’s therapeutic engagement coincides with the prescribed treatment, is among the most important problems in mental health care. The current study investigated the influence of pairing an acute positive reinforcing dopaminer...
Guardado en:
Autores principales: | Martin P. Paulus, Rayus Kuplicki, Teresa A. Victor, Hung-Wen Yeh, Sahib S. Khalsa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da31d9960fa94f9db8584e665b2dd666 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prediction of Suicidality According to Serum Folate Levels in Depressive Patients Receiving Stepwise Pharmacotherapy
por: Jae-Min Kim, et al.
Publicado: (2021) -
Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder
por: Chou WJ, et al.
Publicado: (2018) -
Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study
por: Lunghi C, et al.
Publicado: (2020) -
The COVID-19 Lockdown and CPAP Adherence: The More Vulnerable Ones Less Likely to Improve Adherence?
por: Demirovic S, et al.
Publicado: (2021) -
Factors That Influence Adherence to Medication in Adults With Congenital Heart Disease (ACHD)
por: Tim Halling, et al.
Publicado: (2021)